EDRS
XBI icon

Edmond de Rothschild (Suisse)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Edmond de Rothschild (Suisse)’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$298K Hold
4,500
– – 0.09% 182
2016
Q2 		$243K Buy
+4,500
New +$247K 0.08% 172

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $2.41B AUM 286.33% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Edmond de Rothschild (Suisse)'s XBI Position: Q3 2016 in Review

Edmond de Rothschild (Suisse) held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2016 at 4,500 shares worth $298K. The position accounts for 0.09% of the portfolio, ranked #182.

Edmond de Rothschild (Suisse) first reported a position in XBI in Q2 2016 and has held it in 2 quarters since. 228 funds tracked by Wall St. Rank hold XBI as of Q3 2016.

  • Edmond de Rothschild (Suisse) held 4,500 shares of State Street SPDR S&P Biotech ETF worth $298K as of Q3 2016.
  • Edmond de Rothschild (Suisse) left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2016.
  • State Street SPDR S&P Biotech ETF made up 0.09% of Edmond de Rothschild (Suisse)'s portfolio in Q3 2016, its #182 holding.
  • Edmond de Rothschild (Suisse) first reported a position in State Street SPDR S&P Biotech ETF in Q2 2016 and has held it in 2 quarters since.
  • 228 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2016.

Based on Edmond de Rothschild (Suisse)'s 13F filing for Q3 2016, filed 14 Nov 2016.